There is no set time limit for how long you can take Ozempic for weight loss. Because obesity is treated as a chronic condition, the medical expectation is that most people will stay on the medication indefinitely to maintain their results. Stopping typically leads to significant weight regain, which is the main reason doctors prescribe it as an ongoing treatment rather than a short course.
That said, Ozempic (semaglutide) is technically FDA-approved for type 2 diabetes and cardiovascular risk reduction, not weight loss specifically. Its higher-dose sibling, Wegovy, carries the weight management approval. Many doctors prescribe Ozempic off-label for weight loss at lower doses, and that off-label status can affect insurance coverage, cost, and how long you’re able to continue filling the prescription.
What Happens When You Stop
This is the single most important thing to understand about duration: the medication works while you take it, and the weight comes back when you don’t. A 2025 systematic review published in The BMJ estimated that people regain about 0.8 kg (roughly 1.7 pounds) per month after stopping newer medications like semaglutide. That adds up to roughly 10 kg (22 pounds) within the first year off the drug, with a projected return to baseline weight within about 1.5 years of stopping.
The STEP 4 clinical trial illustrated this clearly. After 20 weeks on semaglutide, participants had lost an average of 10.6% of their body weight. Those who continued the medication for another 48 weeks lost an additional 7.9%. Those switched to a placebo gained back 6.9% over the same period. The gap between the two groups was nearly 15 percentage points, all determined by whether they kept taking the drug.
This pattern is why most prescribers frame semaglutide as a long-term or lifelong medication, similar to blood pressure or cholesterol drugs. You wouldn’t stop a statin and expect your cholesterol to stay low on its own. The same logic applies here.
How Long Clinical Trials Have Lasted
The longest major trials for semaglutide in weight management ran for about 68 to 72 weeks, or roughly a year and a half. These trials established that the drug continues working throughout that window, with weight loss generally plateauing somewhere around 60 to 68 weeks. Beyond that timeframe, the goal shifts from losing weight to maintaining the loss.
A systematic review and meta-analysis of randomized controlled trials found that the side effect profile over these longer periods remained consistent with what’s seen in shorter studies. Gastrointestinal issues like nausea, vomiting, and diarrhea were about 47% more common in people taking semaglutide compared to placebo, but most of these were mild to moderate and didn’t require stopping the medication. No new safety signals emerged with longer use.
The Thyroid Cancer Question
The prescribing label carries a warning about thyroid tumors based on animal studies in rodents. This has understandably made some people nervous about years-long use. More recent human data, however, suggests the concern may be overblown. A large study found no statistically significant increase in overall thyroid cancer risk for people taking these medications. An apparent spike in diagnoses during the first 12 months disappeared in later years, and researchers traced it to detection bias: people starting semaglutide were significantly more likely to get thyroid ultrasounds (2.1% vs. 1.5% of comparison patients at 12 months), which naturally uncovers more incidental findings.
The FDA warning against use in people with a personal or family history of medullary thyroid carcinoma or a rare condition called MEN2 still stands. But for the general population, routine thyroid screening isn’t considered necessary just because you’re on the medication.
What Ongoing Monitoring Looks Like
Staying on Ozempic long-term means regular check-ins with your prescriber. These visits are less about the drug itself and more about tracking your overall health as your weight changes. Your doctor will monitor for digestive side effects, hydration, energy levels, and any shifts in blood sugar or kidney function. If you have underlying conditions like thyroid disorders or gastrointestinal problems, those may need closer attention.
Dosing adjustments are common over time. Ozempic starts at 0.25 mg weekly for the first four weeks, increases to 0.5 mg, and can go up to a maximum of 2 mg weekly depending on your response and tolerance. Some people find they can maintain their results on a lower dose after the initial weight loss phase, which can also help manage side effects and cost.
Insurance and Cost Barriers to Long-Term Use
Even if the medical answer is “stay on it as long as it’s working,” the practical answer often depends on whether you can afford to. Ozempic prescribed off-label for weight loss is frequently not covered by insurance. Medicare Part D currently excludes coverage for medications used solely to treat obesity, though the Centers for Medicare and Medicaid Services has proposed changing that policy. Private insurers vary widely, and many require prior authorization or periodic re-evaluation to continue coverage.
If your prescription is written for a covered indication like type 2 diabetes, coverage is more straightforward. But for people using Ozempic purely for weight management, out-of-pocket costs can run over $1,000 per month, making indefinite use a financial question as much as a medical one. Some people cycle on and off the medication for cost reasons, though the weight regain data suggests this comes with predictable trade-offs.
Can You Eventually Stop and Keep the Weight Off?
Some people hope to use Ozempic temporarily, build better habits during treatment, and then maintain their weight through diet and exercise alone. The clinical evidence suggests this is difficult for most people. The weight regain seen in trials occurred despite participants continuing lifestyle interventions after stopping the drug. The medication changes appetite signaling at a biological level, and when it’s removed, those signals return to their pre-treatment state.
That said, not everyone regains all the weight, and individual results vary. People who make significant, sustained changes to their eating patterns and physical activity during treatment may hold onto some of their progress. But planning to use the medication as a temporary boost rather than an ongoing treatment means accepting a high likelihood of partial or full regain within one to two years of stopping.